These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64 related articles for article (PubMed ID: 26090398)
21. [Relationship between the expression of the genes encoding the key enzymes for cytarabine metabolism and the pharmacokinetics of cytarabine in the treatment of childhood acute leukemia with high-dose cytarabine]. Xie XT; Jiang SY; Li BS; Yang LL Zhonghua Er Ke Za Zhi; 2008 Apr; 46(4):276-80. PubMed ID: 19099730 [TBL] [Abstract][Full Text] [Related]
22. CDA gene polymorphisms and enzyme activity: genotype-phenotype relationship in an Italian-Caucasian population. Carpi FM; Vincenzetti S; Ubaldi J; Pucciarelli S; Polzonetti V; Micozzi D; Mignini F; Napolioni V Pharmacogenomics; 2013 May; 14(7):769-81. PubMed ID: 23651026 [TBL] [Abstract][Full Text] [Related]
23. Association of polymorphisms of cytosine arabinoside-metabolizing enzyme gene with therapeutic efficacy for acute myeloid leukemia. Xu PP; Chen BA; Feng JF; Cheng L; Xia GH; Li YF; Qian J; Ding JH; Lu ZH; Wang XM; Xu K; Schultz M Chin Med J (Engl); 2012 Jun; 125(12):2137-43. PubMed ID: 22884143 [TBL] [Abstract][Full Text] [Related]
25. Treatment-related mortality in children with acute myeloid leukaemia in Central America: incidence, timing and predictors. Gupta S; Bonilla M; Valverde P; Fu L; Howard SC; Ribeiro RC; Sung L Eur J Cancer; 2012 Jun; 48(9):1363-9. PubMed ID: 22082459 [TBL] [Abstract][Full Text] [Related]
26. Variability in transport and biotransformation of cytarabine is associated with its toxicity in peripheral blood mononuclear cells. Parmar S; Seeringer A; Denich D; Gärtner F; Pitterle K; Syrovets T; Ohmle B; Stingl JC Pharmacogenomics; 2011 Apr; 12(4):503-14. PubMed ID: 21521023 [TBL] [Abstract][Full Text] [Related]
29. Ethnic differences of two non-synonymous single nucleotide polymorphisms in CDA gene. Sugiyama E; Lee SJ; Lee SS; Kim WY; Kim SR; Tohkin M; Hasegawa R; Okuda H; Kawamoto M; Kamatani N; Sawada J; Kaniwa N; Saito Y; Shin JG Drug Metab Pharmacokinet; 2009; 24(6):553-6. PubMed ID: 20045991 [TBL] [Abstract][Full Text] [Related]
30. PCR-based methods for CDA K27Q and A70T genotyping: genotypes and alleles distribution in a central Italy population. Carpi FM; Vincenzetti S; Micozzi D; Vita A; Napolioni V Mol Biol Rep; 2010 Oct; 37(7):3363-8. PubMed ID: 19941076 [TBL] [Abstract][Full Text] [Related]
31. SNP analyses in cytarabine metabolizing enzymes in AML patients and their impact on treatment response and patient survival: identification of CDA SNP C-451T as an independent prognostic parameter for survival. Mahlknecht U; Dransfeld CL; Bulut N; Kramer M; Thiede C; Ehninger G; Schaich M Leukemia; 2009 Oct; 23(10):1929-32. PubMed ID: 19458626 [No Abstract] [Full Text] [Related]
32. Cytidine deaminase genotype and toxicity of cytosine arabinoside therapy in children with acute myeloid leukemia. Bhatla D; Gerbing RB; Alonzo TA; Conner H; Ross JA; Meshinchi S; Zhai X; Zamzow T; Mehta PA; Geiger H; Perentesis J; Davies SM Br J Haematol; 2009 Feb; 144(3):388-94. PubMed ID: 19036079 [TBL] [Abstract][Full Text] [Related]
33. Differential allelic expression in leukoblast from patients with acute myeloid leukemia suggests genetic regulation of CDA, DCK, NT5C2, NT5C3, and TP53. Jordheim LP; Nguyen-Dumont T; Thomas X; Dumontet C; Tavtigian SV Drug Metab Dispos; 2008 Dec; 36(12):2419-23. PubMed ID: 18775979 [TBL] [Abstract][Full Text] [Related]